STAT
AUGUST 17, 2023
The health care industry didn’t just provide a safe haven for jittery stock investors in 2022, a year defined by inflation and higher interest rates. It also provided a stable stream of wealth for top executives, who collectively pocketed billions of dollars in what was otherwise a rough patch for the economy. By almost every measure, 2022 was a bad year for the stock market.
PharmaVoice
AUGUST 17, 2023
The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 17, 2023
When someone says the word embryo, what do you think of? Probably that picture you’ve seen a thousand times on a thousand different news articles: a translucent orb swelling with cytoplasm being prodded by a microinjection needle under the light of a microscope. The mainstreaming of IVF, or in vitro fertilization, has familiarized new generations of people with what the earliest stages of human development entails.
BioPharma Dive
AUGUST 17, 2023
A combination of Trodelvy and Merck’s Keytruda appears active against lung tumors, but has a high bar to clear and faces competition from AstraZeneca and Daiichi Sankyo.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
AUGUST 17, 2023
A South African court ruled the government must disclose contracts signed with pharmaceutical companies for Covid-19 vaccines, a victory for advocates who alleged that authorities may have overpaid for the shots and that the lack of transparency masked pharmaceutical profits at the public’s expense. At issue are contracts signed by the South African government with several companies — including Johnson & Johnson and Pfizer — that provided millions of Covid-19 vaccines du
Drug Patent Watch
AUGUST 17, 2023
Annual Drug Patent Expirations for LUMASON Lumason is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. There are two patents protecting… The post New patent for Bracco drug LUMASON appeared first on DrugPatentWatch - Make Better Decisions.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
AUGUST 17, 2023
NICE has recommended four digital platforms to be used by NHS weight management services to help assess patients and prescribe weight-loss medication for obesity. Draft guidance has proposed the use of platforms that can help clinicians support patients psychologically, provide monitoring, and even allow prescription. The platforms put forward – Liva, Oviva, Roczen, and Second Nature […] The post NICE gives go ahead to digital platforms for weight loss services appeared first on The Pharma
STAT
AUGUST 17, 2023
Precision medicine driven by genetic health care is knocking on the door. It offers hope that, sooner than later, we can address health problems like Alzheimer’s disease, cancer, and heart disease that affect the lives of so many Americans. For many patients, the first step will be genetic testing and counseling by a board-certified genetic counselor.
Express Pharma
AUGUST 17, 2023
Event: LPC 175 Conclave: Mumbai Organiser: Live Pharma Coalition Theme: Future of Pharma: Challenges & Opportunities Date: September 3, 2023 Time: 09:00 am – 05:30 pm Venue: Auditorium, SIES School of Business Studies, Nerul, Navi Mumbai Speakers Yogesh Kaushal, President, Alkem Laboratories OP Singh, Global CEO, Akums Drugs Venugopal Vijayendran, President, Intas Pharma Shahbaz Alam, President, Pharma Ratna Manoj Saxena, MD, Bayer India & SE Asia Dilip Singh Rathore, President India Bus
STAT
AUGUST 17, 2023
What difference does a day make? Who gets to have gene therapy? And are biotech startups OK? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
AUGUST 17, 2023
The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study - News - PharmaTimes
STAT
AUGUST 17, 2023
There are people in your life who influence and shape how you see the world. For me, one of these people is Terry Moakley, a warm and welcoming family friend, a veteran of the Vietnam War, and a fervent advocate for people with disabilities. After he became a quadriplegic as a result of an injury, he began a decades-long career dedicated to improving disability access.
The Pharmacist
AUGUST 17, 2023
Using the incorrect cuff size when taking blood pressure measurements can lead to significant over and under-estimations, according to the findings of a randomised trial by US researchers. Although clinical practice guidelines recommend the selection of an appropriately sized cuff based on mid-arm circumference before taking a blood pressure (BP) reading, the extent to which miscuffing […] The post Incorrect cuff size can significantly impact BP readings appeared first on The Pharmacist.
STAT
AUGUST 17, 2023
Blue Shield of California, a health insurance company that covers almost 5 million people, is restructuring how it will pay for prescription drugs by dividing the work up among five different vendors — two of which include Amazon and Mark Cuban’s pharmacy company. Starting in 2024, Blue Shield will rely less on CVS Health’s pharmacy benefit manager, CVS Caremark, a move that led Wall Street to sell off CVS’ stock by more than 9%.
Express Pharma
AUGUST 17, 2023
Hikal announced the receipt of two certifications – the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) confirming the NAI status and the Good Manufacturing Practice (GMP) Certification known as Certificado de Boas Práticas de Fabricação (CBPF) by the Regulatory Authority of Brazil, Agência Nacional de Vigilância Sanitária (ANVISA).
STAT
AUGUST 17, 2023
As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry. The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.
European Pharmaceutical Review
AUGUST 17, 2023
The National Institutes of Health (NIH) has chosen contract development, and manufacturing organisation (CDMO) Exothera SA to develop the manufacturing process for its intranasal vaccine against SARS-CoV-2 coronavirus to treat COVID-19. As an alternative drug delivery method to traditional injected vaccines, live, replicating, intranasal vaccines have potential for effectively interrupting transmission of COVID-19 by inducing the development of immunity in the respiratory tract.
STAT
AUGUST 17, 2023
A feud has erupted between ViiV Healthcare and Doctors Without Borders over a deal to allow the relief organization to purchase an injectable HIV prevention drug, the latest fracas involving the company and efforts to distribute its medication to mostly poor locations around the world. The dispute hinges on a move by the ViiV, which is largely controlled by GSK, to add certain last-minute conditions to a procurement agreement, according to Doctors Without Borders.
Express Pharma
AUGUST 17, 2023
Venus Remedies has launched its R&D drug, Elores, in Oman. Elores is effective against bacterial strains resistant to the last-resort carbapenem class of antibiotics. It is clinically proven to be effective against ICU infections caused by multidrug-resistant extended spectrum beta lactamase (ESBL) and metallo beta lactamase (MBL) -producing gram negative bacteria.
STAT
AUGUST 17, 2023
Top of the morning to you. And a steamy one, it is. In fact, there is more steam rising from the grounds of the Pharmalot campus than from our ritual cup of stimulation. But this is to be expected at this time of year, yes? Our choice today, by the way, is pumpkin spice. In any event, there is work to be done, so as always, we have assembled a few items of interest for you.
Express Pharma
AUGUST 17, 2023
Parexel and Partex announced a preferred strategic alliance designed to leverage artificial intelligence (AI)-powered solutions to accelerate drug discovery and development for biopharma customers worldwide. Parexel’s expertise across Phase I to IV clinical development combined with Partex’s big data and AI capabilities is expected to further advance the efforts of drug developers working to understand the probability of clinical success of assets in their portfolio and recommend oth
European Pharmaceutical Review
AUGUST 17, 2023
Use of the immune checkpoint inhibitor immunotherapy drug ipilimumab plus nivolumab has been shown to be effective as second-line therapy in metastatic melanoma that is resistant to PD-1 inhibitors. In a Phase II clinical trial, the anti-cancer treatment extended progression-free survival (PFS) by 37 percent compared to participants who received ipilimumab alone.
Outsourcing Pharma
AUGUST 17, 2023
BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers and shakers in the pharma industry. From Karuna Therapeutics to IO Biotech, we break down the key changes on the pharmaceutical job ladder.
European Pharmaceutical Review
AUGUST 17, 2023
Recent EU approval means adults who have four or more migraine days per month can now access the first and only once-daily oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant). Authorisation of AbbVie’s AQUIPTA ® (atogepant) by the European Commission (EC) is based on two Phase III studies which demonstrated that “AQUIPTA provides significant and sustained reduction of mean monthly migraine days [for both chronic and episodic migraines ],” stated Dr Patricia Pozo-
Pharma Times
AUGUST 17, 2023
The therapy involves long-term enzyme replacement therapy for aduls with Fabry disease - News - PharmaTimes
Outsourcing Pharma
AUGUST 17, 2023
The UKâs Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorizations for Pombliti + Opfolda, a two-component therapy to treat Pompe disease.
The Guardian - Pharmaceutical Industry
AUGUST 17, 2023
Health officials support proposal for private provision of vaccines after age limit on NHS booster programme raised to 65 Covid booster vaccines are expected to become available for the UK public to buy for the first time after health officials supported the proposal. Pharmacists and private clinics will be allowed to offer jabs for sale on the high street, as they do with the flu vaccine.
PharmaTech
AUGUST 17, 2023
Eurofins BioPharma Product Testing’s Biologics Raw Materials testing team has vast experience in cell & gene therapy testing, including evaluating critical quality attributes for ancillary and raw materials.
Express Pharma
AUGUST 17, 2023
CPHI, the global pharma exhibition, organised by Informa, will be held in Fiera Milano (Rho) from October 8-10, 2024. It will be hosted in the city of Milan for the second time in three years in recognition of the massive pharma ingredients and manufacturing industry in the region. Italy is one of Europe’s largest producers and exporters of ingredients – around 85 per cent are exported to North America, the EU and Japan – with the Milan region at the centre of its pharma base.
World Pharma News
AUGUST 17, 2023
People who adhere to a Mediterranean lifestyle - which includes a diet rich in fruits, vegetables, and whole grains; healthy eating habits like limiting added salts and sugars; and habits promoting adequate rest, physical activity, and socialization - have a lower risk of all-cause and cancer mortality, according to a new study led by La Universidad Autónoma de Madrid and Harvard T.H.
pharmaphorum
AUGUST 17, 2023
UK sets aside £210m for antimicrobial resistance project Phil.
Outsourcing Pharma
AUGUST 17, 2023
Integrated drug formulation and clinical trials company, BDD Pharma, will be expanding its phase appropriate development, manufacturing, and clinical testing services after a Â2 million ($1.3 million) investment.
pharmaphorum
AUGUST 17, 2023
Unlocking superpower status: The crucial role of space in scaling up Mike.
PharmaTech
AUGUST 17, 2023
A panel of experts from bio/pharmaceutical companies discuss plasmids to establish specifications using a risk-based approach to manage supply, including the response to cell & gene therapy industry feedback, future outlook and re-evaluating plasmid risks.
pharmaphorum
AUGUST 17, 2023
Changing Faces: Pharma and biotech hires from July 2023 Mike.
Expert insights. Personalized for you.
246 
Let's personalize your content